BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | May 10, 2017
Financial News

Cytokinetics raises $75M follow-on

BioCentury | Feb 3, 2017
Company News

Amgen, Cytokinetics, Royalty Pharma deal

BioCentury | Dec 2, 2016
Clinical News

Oral omecamtiv mercabil: Ph III started

BioCentury | Dec 2, 2016
Clinical News

Cytokinetics bags milestone as Amgen starts CVOT

BioCentury | Oct 29, 2015
Top Story

Amgen lifts guidance, beats estimates

BioCentury | Sep 9, 2013
Clinical News

Omecamtiv mecarbil: Phase IIb data

BioCentury | Jul 1, 2013
Finance

3Q Financial Markets Preview: Punctuated equilibrium

Money managers see a quiet 3Q13 punctuated by some big events
BioCentury | Mar 25, 2013
Clinical News

Omecamtiv mecarbil: Completed Phase IIb enrollment

Items per page:
1 - 10 of 14